How much does it cost to research and develop a new drug? A systematic review and assessment


15 October 2021 - Debate over the viability of the current commercial research and development model is on-going. 

A controversial theme is the cost of bringing a new molecular entity to market. Estimates of total average capitalised pre-launch R&D costs varied widely, ranging from $161 million to $4.54 billion (2019 US$).

Read PharmacoEconomics article

Michael Wonder

Posted by:

Michael Wonder